/
CRVO
$2.93-$0.14 (-4.56%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$41.5M
14M shares
52-week range
$2.13 – $11.25
9% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-4.66
CervoMed Inc. Common Stock
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
www.cervomed.com- Employees
- 15
- IPO / List date
- Jun 18, 1996
- HQ
- BOSTON, MA
Held by traders on TradeandTell
No one on the platform currently holds CRVO.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 63,904 | $251.8K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2022-04-19 | 1-for-50reverse |
| 2018-12-14 | 1-for-15reverse |
Recent trades on TradeandTell
No one on the platform has traded CRVO yet.
